Elsevier

Gynecologic Oncology

Volume 71, Issue 2, November 1998, Pages 254-257
Gynecologic Oncology

Regular Article
Assessment of Archived Paraffin-Embedded Cervical Condyloma Tissues for Mycoplasma-Conserved DNA Using Sensitive PCR–ELISA

https://doi.org/10.1006/gyno.1998.5177Get rights and content

Abstract

Clinically, it is important to detect mycoplasmas because these organisms have been implicated in gastric and ovarian cancer, pneumonia, postabortal fever, pelvic inflammatory disease, pyelonephritis, endometritis, urethritis, perinatal mortality, arthritis, spontaneous abortion, infertility and interference with sperm development and they act as cofactors catalyzing the HIV disease state. Recently, the combined polymerase chain reaction and enzyme-linked immunosorbent assay method targeting the consensus DNA of over 15 species of mycoplasmas was shown to be superior for the detection of mycoplasmas. The objective was to determine if there was an association between mycoplasmas and cervical neoplasia. Cervical tissues, histopathologically categorized by cervical intraepithelial neoplasia (CIN) grade, flat or exophytic, and acanthosis or koilocytotic, were used. The results showed that mycoplasmas DNA were present in 21.4% of the condyloma tissues and in 33.3% of condyloma tissues with CIN. In contrast, mycoplasmas DNA were not detected when there were no CIN. The presence or absence of human papillomavirus (HPV) did not make a difference. Mycoplasmas DNA were present in 40.0 and 12.5% of the exophytic and flat condylomas, respectively. A higher percentage of cervical tissues graded with slight koilocytosis had (P= 0.05) mycoplasmas DNA compared with tissues graded with moderate koilocytosis. The detection of mycoplasmas DNA in archived cervical condyloma tissues with CIN corroborated previous reports of an association between mycoplasmas and CIN. However, the association between mycoplasmas and the presence of HPV could not be made in this study.

References (35)

  • G Rawadi et al.

    Advances in PCR-based detection of mycoplasmas contaminating cell cultures

    PCR Methods Appl

    (1995)
  • GH Cassell et al.

    Mycoplasmas as agents of human disease

    N Engl J Med

    (1981)
  • HW Horne et al.

    Subclinical endometrial inflammation and T-mycoplasma

    Int J Fertil

    (1973)
  • D Taylor-Robinson et al.

    The genital mycoplasmas

    N Engl J Med

    (1980)
  • BC Cole et al.

    Mycoplasma infections as models of chronic joint inflammation

    Arthritis Rheum

    (1979)
  • J Friberg

    Mycoplasmas and ureaplasmas in reproductive failure

    Contemp Obstet Gynecol

    (1983)
  • M Upadhaya et al.

    The effect of ureaplasma urealyticum on semen characteristics

    Fertil Steril

    (1994)
  • Cited by (22)

    • Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine

      2014, Journal of Biological Chemistry
      Citation Excerpt :

      The association of different bacteria (e.g. Helicobacter pylori, Salmonella typhi, Chlamidophyla pneumoniae, Mycoplasma sp., and others) with tumor tissue in cancer patients has been repeatedly reported (12, 13). A variety of studies have shown a higher infection ratio (∼30 to 50%) of human solid tumors by mycoplasmas (mostly by Mycoplasma hyorhinis) compared with healthy or non-malignant diseased tissues (14–23). Such preferential colonization of tumor tissue by prokaryotes may be attributed to: (i) aberrant vascularization, (ii) an increased nutrient availability (due to necrotic tissue) at the tumor site, and/or (iii) tumor-directed bacterial chemotaxis (13).

    • Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs

      2015, FEBS Open Bio
      Citation Excerpt :

      This was demonstrated for both pyrimidine- and purine-derived antimetabolites including gemcitabine, floxuridine, trifluridine, cladribine, and others [6–10]. There have been several reports that mycoplasmas have been shown to preferentially colonize tumor tissue in patients [11–20]. If this phenomenon can be broadly confirmed and since nucleoside-derived drugs are established cornerstones in the chemotherapy of several cancers [21], the presence of such prokaryotes in the tumor microenvironment may be a confounding factor for the efficiency of anticancer nucleoside analogues and of importance for optimization of nucleoside-based cancer treatment [22,23].

    • Inhibition of pyrimidine and purine nucleoside phosphorylases by a 3,5-dichlorobenzoyl-substituted 2-deoxy-d-ribose-1-phosphate derivative

      2012, Biochemical Pharmacology
      Citation Excerpt :

      Due to the nature of these drugs they may be subject to enzymatic inactivation (e.g. deamination, dephosphorylation or phosphorolysis) by enzymes involved in nucleo(s)(t)ide catabolism. Several studies show that the expression of NPs is upregulated in tumor cells [10–12] and bacterial NPs may be abundantly present in the tumor microenvironment due to the preferential colonisation of malignant tissues by mycoplasmas [31–37]. Also immunocompromised patients (e.g. patients suffering from AIDS) are known to be prone to mycoplasma infections [38,39].

    • The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2′-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes

      2011, Biochemical Pharmacology
      Citation Excerpt :

      Pehlivan et al. found 22% of small cell lung cancer tissue samples and >80% kidney tissue samples of patients suffering renal cell carcinoma to be infected with mycoplasmas compared to 5% and 14%, respectively, in control tissue samples [16,17]. Chan et al. reported a 59% mycoplasma infection rate in ovarian cancer tissues [18] and other studies also reported a high infection rate in gastric [19,20] and cervical condyloma tissues [21]. Due to their reduced set of genes, mycoplasmas lack the pathway for de novo pyrimidine and purine synthesis and therefore express a wide array of salvage nucleo(s)(t)ide-metabolizing enzymes, such as thymidine phosphorylase (TP), deoxycytidine deaminase, etc. [22–25].

    • The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy

      2008, Biochemical Pharmacology
      Citation Excerpt :

      A possible association between mycoplasmas and leukaemia has already been suggested in the 1960s [22,23]. More recently, mycoplasmas were detected in tissues of ovarian and cervical cancer, by using sensitive PCR-ELISAs [24,25]. In addition, Mycoplasma penetrans was found to be associated with Kaposi's sarcoma [26].

    View all citing articles on Scopus

    Innis, M, AGelfand, D, HSninsky, J, JWhite, T, J

    1

    To whom reprint requests should be addressed. Fax: (909)-824-4167.

    View full text